Relation of soluble and platelet p-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy
- 1 March 2001
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (6) , 774-777
- https://doi.org/10.1016/s0002-9149(00)01502-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effects of Monoclonal Antibody to P-Selectin and Analogue of Sialyl Lewis X on Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary ArteriesCirculation, 1997
- Dietary Coenzyme Q10 Supplementation Alters Platelet Size and Inhibits Human Vitronectin (CD51/CD61) Receptor ExpressionJournal of Cardiovascular Pharmacology, 1997
- In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.Proceedings of the National Academy of Sciences, 1996
- Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin?Coronary Artery Disease, 1995
- Leukocyte-endothelial adhesion moleculesBlood, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.Journal of Clinical Investigation, 1993
- Flow Cytometric Measurement of Platelet Function and Reticulated PlateletsAnnals of the New York Academy of Sciences, 1993
- Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes.Journal of Biological Chemistry, 1990